Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial

Marc G Jeschke1, Gabriela A Kulp, Robert Kraft

  • 1Shriners Hospitals for Children, Galveston, TX 77550, USA. majeschk@utmb.edu

Insights

Intensive insulin therapy in severely burned children significantly reduced infections and improved organ function. This approach alleviates post-burn insulin resistance and the body's catabolic response, enhancing recovery.

Area of Science:

  • Pediatric critical care
  • Burn management
  • Endocrinology

Background:

  • Hyperglycemia and insulin resistance increase morbidity and mortality in severely burned patients.
  • Glycemic control is crucial for improving clinical outcomes in burn patients.
  • No prior prospective randomized studies evaluated intensive insulin therapy's impact on post-burn outcomes.

Purpose of the Study:

  • To determine if intensive insulin therapy improves post-burn morbidity in severely burned pediatric patients.
  • To assess the effects of intensive insulin therapy on mortality, sepsis, organ function, and metabolic responses.

Main Methods:

  • A prospective randomized trial involving 239 severely burned pediatric patients (burns >30% total body surface area).
  • Patients were randomized to intensive insulin treatment (n=60) or standard care (control, n=179).
  • Evaluated outcomes included infection rates, sepsis, organ function markers, inflammatory responses, and mortality.

Main Results:

  • Intensive insulin therapy significantly reduced infections and sepsis compared to controls (P < 0.05).
  • Improved organ function was observed, indicated by better serum markers, DENVER2 scores, and ultrasound findings (P < 0.05).
  • Intensive insulin therapy alleviated post-burn insulin resistance, reduced the catabolic response, and dampened inflammation (P < 0.05).

Conclusions:

  • Intensive insulin therapy significantly improves post-burn morbidity in severely burned pediatric patients.
  • The study demonstrates benefits in reducing infections, enhancing organ function, and managing metabolic and inflammatory responses.
  • Further research may explore the impact on mortality, though not statistically significant in this trial (P = 0.14).
Abstract